251 related articles for article (PubMed ID: 15498532)
1. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer.
LeGatt DF; Shalapay CE; Cheng SB
Clin Biochem; 2004 Nov; 37(11):1022-30. PubMed ID: 15498532
[TBL] [Abstract][Full Text] [Related]
2. [The EMIT Tacrolimus assay: development of application protocol for Roche Hitachi 902 analyzer].
Yargui L; Berhoune A
Ann Biol Clin (Paris); 2008; 66(6):657-64. PubMed ID: 19091665
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
[TBL] [Abstract][Full Text] [Related]
4. Application of the EMIT 2000 Tacrolimus assay on the Abbott Architect c8000 high volume clinical chemistry analyzer.
Boer K; Deufel T; Schmidt D; Streck S; Kiehntopf M
Clin Biochem; 2006 Oct; 39(10):1041-3. PubMed ID: 16979616
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
[TBL] [Abstract][Full Text] [Related]
6. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
Westley IS; Taylor PJ; Salm P; Morris RG
Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
[TBL] [Abstract][Full Text] [Related]
7. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
[TBL] [Abstract][Full Text] [Related]
8. Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer.
Griffey MA; Hock KG; Kilgore DC; Wei TQ; Duh SH; Christenson R; Scott MG
Clin Chim Acta; 2007 Sep; 384(1-2):48-51. PubMed ID: 17588555
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
Saint-Marcoux F; Debord J; Parant F; Labalette M; Kamar N; Rostaing L; Rousseau A; Marquet P
Ther Drug Monit; 2011 Apr; 33(2):171-7. PubMed ID: 21383655
[TBL] [Abstract][Full Text] [Related]
10. A rapid, simple and sensitive liquid chromatography-tandem mass spectrometry method for routine clinical monitoring of tacrolimus with the Waters Masstrak™ immmunosuppressant kit.
Guilhaumou R; Lacarelle B; Sampol-Manos E
Methods Find Exp Clin Pharmacol; 2010 Dec; 32(10):737-43. PubMed ID: 21225010
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Dade Behring Syva EMIT 2000 tacrolimus assay on the Bayer Advia 1650.
Stephen DW; Rooke P; Clark S; Coutts M; Crowe L; Docherty D
Ann Clin Biochem; 2003 Nov; 40(Pt 6):697-700. PubMed ID: 14629812
[TBL] [Abstract][Full Text] [Related]
12. Effect of the hematocrit and its correction on the relationship between blood tacrolimus concentrations obtained using the microparticle enzyme immunoassay (MEIA) and enzyme multiplied immunoassay technique (EMIT).
Bouzas L; Ortega FJ; Casado P; Arranz MI; Carcas A; Tutor JC
Clin Lab; 2007; 53(9-12):591-6. PubMed ID: 18257466
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
[TBL] [Abstract][Full Text] [Related]
15. Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography-electrospray mass spectrometry with the enzyme multiplied immunoassay technique.
Ansermot N; Fathi M; Veuthey JL; Desmeules J; Rudaz S; Hochstrasser D
Clin Biochem; 2008 Jul; 41(10-11):910-3. PubMed ID: 18358833
[TBL] [Abstract][Full Text] [Related]
16. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells.
Capron A; Musuamba F; Latinne D; Mourad M; Lerut J; Haufroid V; Wallemacq PE
Ther Drug Monit; 2009 Apr; 31(2):178-86. PubMed ID: 19057467
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a rapid micro-scale assay for tacrolimus by liquid chromatography-tandem mass spectrometry.
Keevil BG; McCann SJ; Cooper DP; Morris MR
Ann Clin Biochem; 2002 Sep; 39(Pt 5):487-92. PubMed ID: 12227855
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of C0 and C2 blood concentrations of cyclosporine on the Roche Hitachi 902 analyzer.
Yargui L; Berhoune A
Transplant Proc; 2009 Nov; 41(9):3713-9. PubMed ID: 19917373
[TBL] [Abstract][Full Text] [Related]
19. Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and Abbott IMx methods.
De BK; Jimenez E; De S; Sawyer JC; McMillin GA
Clin Chim Acta; 2009 Dec; 410(1-2):25-30. PubMed ID: 19751714
[TBL] [Abstract][Full Text] [Related]
20. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
Wallemacq P; Goffinet JS; O'Morchoe S; Rosiere T; Maine GT; Labalette M; Aimo G; Dickson D; Schmidt E; Schwinzer R; Schmid RW
Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]